Myocardial protection of contractile function after global ischemia by physiologic estrogen replacement in the ovariectomized rat

Journal of Molecular and Cellular Cardiology

Volumn 29, Issue 9, 1997, Pages 2403-2414

  Kolodgie, Frank D ^a   Farb, Andrew ^a   Litovsky, Silvio H ^a   Narula, Jagat ^b   Jeffers, Lisa A ^a   Lee, Sue J ^a   Virmani, Renu ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

17 estradiol; Contractile function; Ischemia; Preconditioning; Reperfusion

Indexed keywords

CREATINE KINASE; ESTRADIOL; ESTROGEN; LACTATE DEHYDROGENASE; LACTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA CLAMPING; AORTA FLOW; ARTICLE; CONDITIONING; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CREATINE KINASE BLOOD LEVEL; DISEASE SEVERITY; ESTROGEN BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; HEART FUNCTION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE DP-DT; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART OUTPUT; HEART PERFUSION; HEART PROTECTION; HEMODYNAMICS; ISOLATED HEART; LACTATE BLOOD LEVEL; LACTATE DEHYDROGENASE BLOOD LEVEL; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALIA;

EID: 0031239326     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1997.0476     Document Type: Article

References (36)

1. BARTA E, STREC V, OKOLICANY J, RAJECOVA O, 1989. Protective effect of oestradiol on the heart of rats exposed to acute ischaemia. Physiol Bohemoslov 38: 193-200.
2. BIVENS CL, OLSTER DH, 1997. Abnormal estrous cyclicity and behavioral hyporesponsiveness to ovarian hormones in genetically obese Zucker female rats. Endocrinology 138: 143-148.
3. BUSH TL, BARRETT-CONNOR E, COWAN LD, CRIQUI MH, WALLACE RB, SUCHINDRAN CM, TYROLER HA, RIFKIND BM, 1987. Cardiovascular mortality and non-contraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 75: 1102-1109.
4. BUSH TL, FRIED LP, BARRETT-CONNOR E, 1988. Cholesterol, lipoproteins, and coronary heart disease in women. Clin Chem 34: B60-B70.
5. CAVE AC, HEARSE DJ, 1992. Ischaemic preconditioning and contractile function: studies with normothermic and hypothermic global ischaemia. J Mol Cell Cardiol 24: 1113-1123.
6. COHEN MV, DOWNEY JM, 1996. Myocardial preconditioning promises to be a novel approach to the treatment of ischemic heart disease. Annu Rev Med 47: 21-29.
7. COLLINS P, ROSANO GM, JIANG C, LINDSAY D, SARREL PM, POOLE-WILSON PA, 1993. Cardiovascular protection by oestrogen - a calcium antagonist effect? Lancet 341: 1264-1265.
8. EVANS RM, 1988. The steroid and thyroid hormone receptor superfamily. Science 240: 889-895.
9. FARHAT MY, ABI-YOUNES S, RAMWELL PW, 1996. Nongenomic effects of estrogen and the vessel wall. Biochem Pharmacol 51: 571-576.
10. FURMAN RH, HOWARD RP, NORCIA LN, KEATY EC, 1958. The influence of androgens, estrogens, and related steroids on serum lipids and lipoproteins. Am J Med 24: 80-97.
11. FURUYA K, CHAUDHURI G, 1993. Estradiol does not influence myocardial superoxide dismutase activity in rabbits. J Cardiovasc Pharmacol 22: 65-68.
12. GROHE C, BRIESEMEISTER G, STIMPEL M, KARAS RH, VETTER H, NEYES L, 1994. Functional estrogen receptors in myocardial and myogenic cells. Circulation 90: 1-538.
13. HALE SL, BIRNBAUM Y, KLONER RA, 1996. beta-Estradiol, but not alpha-estradiol, reduced myocardial necrosis in rabbits after ischemia and reperfusion. Am Heart J 132: 258-262.
14. 2+ in guinea-pig isolated cardiac myocytes. Br J Pharmacol 106: 739-745.
15. KIM YD, CHEN B, BEAUREGARD J, KOURETAS P, THOMAS G, FARHAT MY, MYERS AK, LEES DE, 1996. 17beta-Estradiol prevents dysfunction of canine coronary endothelium and myocardium and reperfusion arrhythmias after brief ischemia/reperfusion. Circulation 94: 2901-2908.
16. 2+ transients underlie stunning? Circ Res 66: 1268-1276.
17. LEGAN SJ, COON GA, KARSCH FJ, 1975. Role of estrogen as initiator of daily LH surges in the ovariectomized rat. Endocrinology 96: 50-56.
18. LEVINE RL, CHEN SJ, DURAND J, CHEN YF, OPARIL S, 1996. Medroxyprogesterone attenuates estrogen-mediated inhibition of neointima formation after balloon injury of the rat carotid artery. Circulation 94: 2221-2227.
19. LEWINN EB, 1984. Steroidal actions of digitalis. Perspect Biol Med 27: 183-199.
20. LIN AL, SHAIN SA, 1985. Estrogen-mediated cytoplasmic and nuclear distribution of rat cardiovascular estrogen receptors. Arteriosclerosis 5: 668-677.
21. LIN AL, GONZALEZ R JR, CAREY KD, SHAIN SA, 1986. Estradiol-17 beta affects estrogen receptor distribution and elevates progesterone receptor content in baboon aorta. Arteriosclerosis 6: 495-504.
22. MARTIN LG, BRENNER GM, JAROLIM KL, BANSCHBACH MW, COONS DL, WOLFE AK, 1993. Effects of sex steroids on myocardial anoxic resistance. Proc Soc Exp Biol Med 202: 288-294.
23. MENDELSOHN ME, KARAS RH, 1994. Estrogen and the blood vessel wall. Curr Opin Cardiol 9: 619-626.
24. OLIVER MF, BOYD GS, 1959. Effect of bilateral ovariectomy on coronary artery disease and serum lipid levels. Lancet ii: 690-694.
25. OSTADAL B, PROCHAZKA J, PELOUCH V, URBANOVA D, WIDIMSKY J, 1984. Comparison of cardiopulmonary responses of male and female rats to intermittent high altitude hypoxia. Physiol Bohemoslov 33: 129-138.
26. RADDINO R, MANCA C, POLI E, BOLOGNESI R, VISIOLO O, 1986. Effects of 17 beta-estradiol on the isolated rabbit heart. Arch Int Pharmacodyn Ther 281: 57-65.
27. ROSENKRANZ-WEISS P, TOMEK RJ, MATTHEW J, EGHBALI M, 1994. Gender-specific differences in expression of mRNAs for functional and structural proteins in rat ventricular myocardium. J Mol Cell Cardiol 26: 261-270.
28. SHIMIZU H, OHTANI K, KATO Y, TANAKA Y, MORI M, 1996. Estrogen increases hypothalamic neuropeotide Y (NPY) mRNA expression in ovariectomized obese rat. Neurosci Lett 204: 81-84.
29. SREELATHAKUMARI KT, MENON VP, LEELAMMA S, 1993. Lipid peroxide metabolism in oophorectomised rats. Indian J Med Res 98: 305-308.
30. STAMPFER MJ, COLDITZ GA, 1991. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 20: 47-63.
31. STAMPFER MJ, WILLETT WC, COLDITZ GA, ROSNER B, SPEIZER FE, HENNEKENS CH, 1985. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med 313: 1044-1049.
32. STUMPF WE, SAR M, AUMULLER G, 1977. The heart: a target organ for estradiol. Science 196: 319-321.
33. TAEGTMEYER H, ROBERTS AF, RAINE AE, 1985. Energy metabolism in reperfused heart muscle: metabolic correlates to return of function. J Am Coll Cardiol 6: 864-870.
34. VOLVSEK A, SUBRAMANIAN R, REBOUSSIN D, 1992. Effects of duration of ischaemia during preconditioning on mechanical function, enzyme release and energy production in the isolated working rat heart. J Mol Cell Cardiol 24: 1011-1019.
35. YAGI K, KOMURA S, 1986. Inhibitory effect of female hormones on lipid peroxidation. Biochem Int 13: 1051-1055.
36. ZIEGELHOFFER A, DZURBA A, VRBJAR N, STYK J, SLEZAK J, 1990. Mechanism of action of estradiol on sodium pump in sarcolemma from the myocardium. Bratisl Lek Listy 91: 902-910.